Anju Software Acquires Sylogent Data Disclosure & Publications Solutions
NEW YORK–(BUSINESS WIRE)–Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired the assets of Sylogent.
“Sylogent has cloud based state of the art software solutions that enhance current Anju solutions in the Medical Affairs and Clinical Trials space,” said Kurien Jacob, CEO of Anju Software. “PUBSTRAT is the only cloud-based solution for publication planning, which is integrated with industry critical scientific journal and medical conference profiles. VTCR is a Clinical Disclosure solution that streamlines compliance with global disclosure and transparency regulation requirements. In addition, Sylogent has SAM for document approvals workflow automation and SYQUENCE, a data and information lifecycle management platform, which is currently being introduced to the industry,” Mr. Jacob continued. Jacob also added that the acquisition of Sylogent is consistent with Anju’s strategy of continuing to enhance its product offering through acquisitions and internal development.Read More